March 16, 2026 · Form 4 insider transaction
Patel Naimish sold 3,150 shares of CRISPR Therapeutics AG at $48.26 per share, a transaction worth $152.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.